$3.36
0.103.07%
In chiusura: -
$3.29
-0.07-2.08%
After hour: 5:00 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Taysha Gene Therapies segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 12
Stima EPS
$-0.090
Stima dei ricavi trimestrali
$1.56M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$8.10M
Analizza lo storico degli utili di Taysha Gene Therapies utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
TSHA | Taysha Gene Therapies | -$0.10 | -$0.09 | — | — | $1.79M | $1.56M | — | — | 11/12/2025 | |
TSHA | Taysha Gene Therapies | -$0.09 | -$0.07 | -$0.09 | -28.57% | $1.11M | $1.65M | $1.99M | 20.29% | 08/12/2025 | |
TSHA | Taysha Gene Therapies | -$0.10 | -$0.09 | -$0.08 | 11.11% | $3.41M | $1.35M | $2.30M | 70.37% | 05/15/2025 | |
TSHA | Taysha Gene Therapies | $0.92 | -$0.08 | -$0.07 | 12.50% | $3.60M | $1.90M | $2.02M | 6.42% | 02/26/2025 | |
TSHA | Taysha Gene Therapies | -$0.93 | -$0.09 | -$0.10 | -11.11% | $4.75M | $1.65M | $1.79M | 8.36% | 11/13/2024 | |
TSHA | Taysha Gene Therapies | -$0.38 | -$0.17 | -$0.09 | 47.06% | $2.40M | $2.66M | $1.11M | -58.20% | 08/12/2024 | |
TSHA | Taysha Gene Therapies | -$0.28 | -$0.11 | -$0.10 | 9.09% | $4.71M | $2.56M | $3.41M | 33.24% | 05/14/2024 | |
TSHA | Taysha Gene Therapies | -$0.34 | -$0.11 | $0.92 | 936.36% | $2.50M | $2.65M | $3.60M | 36.00% | 03/19/2024 | |
TSHA | Taysha Gene Therapies | -$0.64 | -$0.17 | -$0.93 | -447.06% | $0.00 | $1.40M | $4.75M | 239.00% | 11/14/2023 | |
TSHA | Taysha Gene Therapies | -$0.84 | -$0.31 | -$0.38 | -22.58% | $0.00 | $2.00M | $2.40M | 19.75% | 08/14/2023 | |
TSHA | Taysha Gene Therapies | -$1.31 | -$0.35 | -$0.28 | 20.00% | $0.00 | $70.00K | $4.71M | 6622.86% | 05/11/2023 | |
TSHA | Taysha Gene Therapies | -$1.32 | -$0.33 | -$0.34 | -3.03% | $0.00 | $8.18M | $2.50M | -69.41% | 03/28/2023 | |
TSHA | Taysha Gene Therapies | -$1.35 | -$0.82 | -$0.64 | 21.95% | $0.00 | — | $0.00 | — | 11/08/2022 | |
TSHA | Taysha Gene Therapies | -$1.09 | -$0.91 | -$0.84 | 7.69% | $0.00 | — | $0.00 | — | 08/11/2022 | |
TSHA | Taysha Gene Therapies | -$0.87 | -$1.07 | -$1.31 | -22.43% | $0.00 | — | $0.00 | — | 05/16/2022 | |
TSHA | Taysha Gene Therapies | -$1.04 | -$1.25 | -$1.32 | -5.60% | $0.00 | — | $0.00 | — | 03/31/2022 | |
TSHA | Taysha Gene Therapies | -$1.28 | -$1.08 | -$1.35 | -25.00% | $0.00 | — | $0.00 | — | 11/10/2021 | |
TSHA | Taysha Gene Therapies | — | -$0.84 | -$1.09 | -29.76% | — | — | $0.00 | — | 08/16/2021 | |
TSHA | Taysha Gene Therapies | — | -$0.56 | -$0.87 | -55.36% | — | — | $0.00 | — | 05/11/2021 | |
TSHA | Taysha Gene Therapies | — | -$0.37 | -$1.04 | -181.08% | — | — | $0.00 | — | 03/03/2021 | |
TSHA | Taysha Gene Therapies | — | — | -$1.28 | — | — | — | $0.00 | — | 11/12/2020 |
Taysha Gene Therapies (TSHA) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $-0.09 | $-0.07 | -28.6 % |
| Q1 | 2025-05-15 | $-0.08 | $-0.09 | 11.1 % |
| Q4 | 2025-02-26 | $-0.07 | $-0.08 | 12.5 % |
| Q3 | 2024-11-13 | $-0.10 | $-0.09 | -11.1 % |
Taysha Gene Therapies (TSHA) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $1.99M | $1.65M | 20.3 % |
| Q1 | 2025-05-15 | $2.30M | $1.35M | 70.4 % |
| Q4 | 2025-02-26 | $2.02M | $1.90M | 6.42 % |
| Q3 | 2024-11-13 | $1.79M | $1.65M | 8.36 % |
FAQ
Quando Taysha Gene Therapies (NASDAQ:TSHA) riporterà gli utili?
Si prevede che Taysha Gene Therapies (TSHA) fornisca risultati il novembre 12, 2025. Gli ultimi risultati sono stati pubblicati il agosto 12, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Taysha Gene Therapies (NASDAQ:TSHA)?
L'EPS effettivo era $-0.09, che mancato la stima di $-0.07.
Quali sono state le entrate di Taysha Gene Therapies (NASDAQ:TSHA)?
Le entrate effettive sono state $2M, che superato la stima di $1.7M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.